Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus (Q37132930)

18 August 2017

1 reference

title

Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus (English)

1 reference

18 August 2017

4

Ele Ferrannini

1 reference

18 August 2017

Darren K McGuire

1

1 reference

18 August 2017

Jeffrey R Winterfield

series ordinal

2

1 reference

18 August 2017

Jason A Rytlewski

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

Diabetes and Vascular Disease Research

18 August 2017

published in

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

59-66

1 reference

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

The prevention or delay of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Response to Chiasson et al.: Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Design of angiotensin converting enzyme inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Interactions of exercise training and ACE inhibition on insulin action in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Evolution of insulin resistance in coronary artery disease patients on four different pharmacological therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Normalization of insulin resistance in non-obese essential hypertension by cilazapril treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Effect of manidipine and delapril on insulin sensitivity in type 2 diabetic patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

The effect of enalapril with and without hydrochlorothiazide on insulin sensitivity and other metabolic abnormalities of hypertensive patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Hormonal and metabolic effects of enalapril treatment in hypertensive subjects with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Ramipril and the development of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Effect of ramipril on the incidence of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Glucose transport and glucose transporters in muscle and their metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Cross-talk between the insulin and angiotensin signaling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Insulin signalling and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Insulin-induced glucose transporter (GLUT1 and GLUT4) translocation in cardiac muscle tissue is mimicked by bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Insulin sensitivity of muscle capillary recruitment in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Resistance to metabolic actions of insulin and its role in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Potential role of bradykinin in forearm muscle metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Relationship between insulin release, antinatriuresis and hypokalaemia after glucose ingestion in normal and hypertensive man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Prevention of the Glucose Intolerance of Thiazide Diuretics by Maintenance of Body Potassium

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Inflammatory markers and risk of developing type 2 diabetes in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

CAPTOPRIL, ENALAPRIL, AND BLOOD GLUCOSE

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.011

Effect of captopril, losartan, and bradykinin on early steps of insulin action

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.2337/DIAB.46.12.1950

Identifiers

DOI

10.3132/DVDR.2008.011

1 reference

18 August 2017

1 reference